Medicenna Therapeutics Corporation (QX) (MDNAF)
USOTC
Year End March 30 2024 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|---|
CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
Total Assets | 14.48M | 4.38M | 5.19M | 38M | 42.25M | 23.46M | 36.45M | 19.13M |
Total Current Assets | 14.39M | 4.29M | 5.11M | 37.85M | 42.15M | 23.39M | 36.39M | 19.08M |
Cash and Equivalents | 14.04M | 3.94M | 2.37M | 22.7M | 30.38M | 20.54M | 33.6M | 16.98M |
Total Non-Current Assets | 6.66M | 2.16M | 2.62M | 36.15M | 38.15M | 20.84M | 29.49M | 5.19M |
Total Liabilities | 7.83M | 2.21M | 2.57M | 1.85M | 4.11M | 2.62M | 6.96M | 13.94M |
Total Current Liabilities | 7.35M | 1.88M | 2.4M | 1.82M | 4.11M | 2.62M | 3.8M | 2.86M |
Total Non-Current Liabilities | 477k | 337k | 174k | 64k | 0 | 0 | 3.16M | 11.08M |
Total Equity | 6.66M | 2.16M | 2.62M | 36.15M | 38.15M | 20.84M | 29.49M | 5.19M |
Common Equity | 13.46M | 14.3M | 16.62M | 56.58M | 79.59M | 83.67M | 100.92M | 100.92M |
Retained Earnings | -10.4M | -18.08M | -22.79M | -31.07M | -48.36M | -70.93M | -80.98M | -106.45M |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.